Takafumi Koyama

Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study

Kuniko Sunami, Hitoshi Ichikawa, Takashi Kubo et al. · Cancer Science · 2019 · 351 citations · Full text

Actionable Gene Aberrations, Cancer Pathology, Hospital‐based Study +22

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study

Shubham Pant, Martin Schüler, Gopa Iyer et al. · The Lancet Oncology · 2023 · 175 citations · Full text

Fgfr Alterations, Medicine, Pathology +7

First-in-Human Phase 1 Study of MORAb-202, an Antibody–Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α–Positive Advanced Solid Tumors

Toshio Shimizu, Yutaka Fujiwara, Kan Yonemori et al. · Clinical Cancer Research · 2021 · 90 citations · Full text

Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study

Shunji Takahashi, Yutaka Fujiwara, Kenji Nakano et al. · Cancer Science · 2021 · 71 citations · Full text

Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancer

Ikuko Nakamura, Shinji Kohsaka, Masachika Ikegami et al. · npj Precision Oncology · 2021 · 52 citations · Full text